Article

Edinoff, Amber N and Fort, Juliana M and Singh, Christina and Wagner, Sarah E and Rodriguez, Jessica R and Johnson, Catherine A and Cornett, Elyse M and Murnane, Kevin S and Kaye, Adam M and Kaye, Alan D (2022) Alternative options for complex, recurrent pain states using cannabinoids, psilocybin, and ketamine: a narrative review of clinical evidence. Neurology International, 14, (2), pp. 423-436. doi: 10.3390/neurolint14020035.

Edinoff, Amber N and Nix, Catherine A and Orellana, Claudia V and StPierre, Samantha M and Crane, Erin A and Bulloch, Blaine T and Cornett, Elyse M and Kozinn, Rachel L and Kaye, Adam M and Murnane, Kevin S and Kaye, Alan D (2021) Naltrexone implant for opioid use disorder. Neurology International, 14, (1), pp. 49-61. doi: 10.3390/neurolint14010004.

Edinoff, Amber N and Sall, Saveen and Upshaw, William C and Spillers, Noah J and Vincik, LeighAnn Y and De Witt, Adalyn S and Murnane, Kevin S and Kaye, Adam M and Kaye, Alan D (2024) Xylazine: a drug adulterant of clinical concern. Current Pain and Headache Reports, 28, pp. 417-426. https://doi.org/10.1007/s11916-024-01211-z.

Gribben, Andrew and Burke, Tara and Harrington, Colm and Husein, Amanda and Murnane, Kevin S and Hendricks, Peter S and Tobin, Katy and Ivers, Jo-Hanna and Thuery, Guillaume and Harkin, Andrew and Kelly, John R (2024) Amid magic and menace: psychiatrists' attitudes to psilocybin therapy. Irish Journal of Psychological Medicine, 41, (4), pp. 451-459. https://doi.org/10.1017/ipm.2024.49.

Murnane, Kevin S and Edinoff, Amber N and Cornett, Elyse M and Kaye, Alan D (2023) Updated perspectives on the neurobiology of substance use disorders using neuroimaging. Substance Abuse and Rehabilitation, 14, pp. 99-111. doi: 10.2147/SAR.S362861.